Logic-Gated Cell Therapies for Unmet Medical Needs

We are developing the Next Generation of Cell Therapies

Our ImmPACT Bio Platforms

Platform 1 A
Preventing antigen escape

Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address antigen escape

Platform 2
Targeting immunosuppressive microenvironment

TGF-β CAR rewires T cell responses to soluble factors to overcome the immune suppressive microenvironment in cancer

Platform 1 A
Preventing antigen escape

Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address antigen escape

Platform 1 B
Curing autoimmune disease

Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address autoimmunity

Platform 1 B
Curing autoimmune disease

Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address autoimmunity

Platform 3
Distinguishing cancer cells from normal cells

iCAR technology allows specific killing of cancer cells while sparing normal tissue, with potential to treat all solid tumors

Platform 2
Targeting immunosuppressive microenvironment

TGF-β CAR rewires T cell responses to soluble factors to overcome the immune suppressive microenvironment in cancer.

Platform 3
Distinguishing cancer cells from normal cells

iCAR technology allows specific killing of cancer cells while sparing normal tissue, with potential to treat all solid tumors.

Co-founded by and Based on the Research of Pioneering Scientists

Meet Our Team

ImmPACT Bio is developing cutting-edge potent and selective CAR T cell technologies to address key biological challenges in treating grievous diseases.

In 2021 ImmPACT Bio merged with Kalthera Therapeutics.

Get to Know Our Technology

ImmPACT Bio is developing logic-gate-based CAR T platforms that address key challenges for current cell therapies in oncology.

Our technologies are designed to prevent antigen escape, to overcome the immunosuppressive tumor environment, and to cure autoimmune disease.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

ImmPACT Bio is now part of Lyell Immunopharma

If you have a question about a clinical trial, please contact us at info@immpact-bio.com